PolyPid Ltd.
PYPD
Rank in Stocks
#18638
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the... PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.
Share Price
$6.24
Last synced: 2026-11-09
Market Cap
$126.75M
Change (1 day)
1.63%
Change (1 year)
66.40%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade PolyPid Ltd. (PYPD)
Category
Healthcare
EPS for PolyPid Ltd. (PYPD)
EPS as of June 2026 TTM: $-1.48
According to PolyPid Ltd.'s latest financial reports, its current EPS (TTM) is $-1.48. At the end of 2025 the company had an EPS of $-2.09, an increase over its 2024 EPS of $-4.91.
EPS history for PolyPid Ltd. from 2012 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.48 | -29.19% |
| 2025 | $-2.09 | -57.43% |
| 2024 | $-4.91 | -71.10% |
| 2023 | $-16.99 | -72.24% |
| 2022 | $-61.20 | -9.73% |
| 2021 | $-67.80 | 1,413.39% |
| 2020 | $-4.48 | -70.19% |
| 2019 | $-15.03 | -156.29% |
| 2018 | $26.70 | -107.20% |
| 2017 | $-370.58 | 378.29% |
| 2016 | $-77.48 | 105.95% |
| 2015 | $-37.62 | -4.95% |
| 2013 | $-39.58 | 389.85% |
| 2012 | $-8.08 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,158.11% |
US
|
|
| $-7.07 | 377.70% |
US
|
|
| $-5.29 | 257.43% |
AU
|
|
| $12.88 | -970.28% |
BE
|
|
| $21.56 | -1,556.76% |
NL
|
Questions about PolyPid Ltd.'s earnings per share (EPS)
What is PolyPid Ltd.'s earnings per share (EPS)?
PolyPid Ltd.'s earnings per share (EPS) over the last twelve months is $-1.48, as of Jun 2026.
What was PolyPid Ltd.'s earnings per share (EPS) in 2025?
In 2025, PolyPid Ltd.'s earnings per share (EPS) was $-2.09, compared with $-4.91 in 2024.
How has PolyPid Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, PolyPid Ltd.'s earnings per share (EPS) was highest in 2025 ($-2.09) and lowest in 2021 ($-67.80).
How does PolyPid Ltd.'s earnings per share (EPS) compare with similar companies?
PolyPid Ltd.'s earnings per share (EPS) ($-1.48) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.